# EXELIXIS, INC. (EXEL) FY2026 Q2 Balance Sheet

- Company: EXELIXIS, INC. (EXEL)
- Period: As of 2026-07-03
- Filing: Q2 FY2026 10-Q, filed 2026-08-05, accession number 0000939767-26-000098
- Page: https://plicit.ai/financials/exel/fy2026-q2-balance-sheet
- Chart image: https://plicit.ai/charts/exel-fy2026-q2-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2026-07-03. The chart shows assets, liabilities and equity at that date.

- **Assets**: 2,494,234,000 US dollars
- **Current assets**: 1,250,822,000 US dollars
- **Non-current assets**: 1,243,412,000 US dollars
- **Liabilities**: 650,472,000 US dollars
- **Current liabilities**: 361,927,000 US dollars
- **Non-current liabilities**: 288,545,000 US dollars
- **Equity**: 1,843,762,000 US dollars
- **Marketable securities**: 557,937,000 US dollars
- **Trade receivables, net**: 322,213,000 US dollars
- **Cash and cash equivalents**: 281,448,000 US dollars
- **Prepaid expenses and other current assets**: 60,495,000 US dollars
- **Inventory**: 28,729,000 US dollars
- **Non-current marketable securities**: 544,930,000 US dollars
- **Deferred tax assets, net**: 294,205,000 US dollars
- **Right-of-use assets and other non-current assets**: 247,928,000 US dollars
- **Property and equipment, net**: 92,665,000 US dollars
- **Goodwill**: 63,684,000 US dollars
- **Other current liabilities**: 102,662,000 US dollars
- **Accrued compensation and benefits**: 68,629,000 US dollars
- **Rebates and fees due to customers**: 66,711,000 US dollars
- **Accrued clinical trial liabilities**: 59,767,000 US dollars
- **Accounts payable**: 39,062,000 US dollars
- **Accrued collaboration liabilities**: 25,096,000 US dollars
- **Non-current operating lease liabilities**: 165,929,000 US dollars
- **Other non-current liabilities**: 122,616,000 US dollars
- **Additional paid-in-capital**: 2,108,059,000 US dollars
- **Common stock, $0.001 par value; 400,000 shares authorized; issued and outstanding: 248,885 and 262,483 at June 30, 2026, and December 31, 2025, respectively**: 249,000 US dollars
- **Preferred stock, $0.001 par value, 10,000 shares authorized and no shares issued**: 0 US dollars
- **Accumulated deficit**: negative 262,533,000 US dollars
- **Accumulated other comprehensive income (loss)**: negative 2,013,000 US dollars
- **Gross equity (calculated)**: 2,108,308,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.